1,2,4-triazole has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzo, GK; Apgar, JM; Balkovec, JM; Dragovic, J; Fan, W; Flattery, AM; Galgoci, AM; Giacobbe, RA; Gill, CJ; Greenlee, ML; Hsu, MJ; Kahn, JN; Kirwan, R; Lee, S; Liberator, P; Liu, H; Mamai, A; Meng, D; Misura, AS; Motyl, M; Nelson, K; Parker, DL; Peel, M; Powles, M; Racine, F; Sperbeck, D; Wildonger, KJ; Wilkening, RR | 1 |
| Gou, C; Li, C; Li, XZ; Li, YR; Liu, HY; Liu, JC; Piao, HR; Zhang, ML; Zheng, CJ | 1 |
2 other study(ies) available for 1,2,4-triazole and Candidiasis
| Article | Year |
|---|---|
MK-5204: An orally active β-1,3-glucan synthesis inhibitor.
Topics: Administration, Oral; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Glucosyltransferases; Glycosides; Half-Life; Mice; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Triazoles; Triterpenes | 2020 |
Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety.
Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Escherichia coli; Escherichia coli Infections; Humans; Rhodanine; Staphylococcal Infections; Staphylococcus aureus; Thiones; Triazoles | 2015 |